MIP Discovery

06/08/2024

MIP Discovery is now Tozaro! ✨Visit us at http://tozaro.com to see what lies ahead for the rest of 2024 and beyond. We will be retiring this account so be sure to follow us on LinkedIn to stay up to date!
https://www.linkedin.com/company/tozaro/

08/06/2023

Learn how MIP Discovery are developing synthetic affinity reagents for improved diagnostics in our Industry Insights interview with Technology Networks https://www.technologynetworks.com/tn/blog/developing-synthetic-affinity-reagents-for-improved-diagnostics-374235

07/06/2023

Our Head of Chemistry has been chatting to Anna MacDonald at Technology Networks on how ‘MIP Discovery are Developing Synthetic Affinity Reagents for Improved Diagnostics’ – Read the new Industry Insights interview now

To learn more about MIPS and why they are particularly suited for use in in vitro diagnostic assays, we spoke to Dr. Francesco Canfarotta, head of chemistry at MIP Discovery.

06/06/2023

Grab a coffee and have a read of our new paper published in Biosensors and Bioelectronics -Electroactive molecularly imprinted polymer nanoparticles for selective glyphosate determination

Redox-active molecularly imprinted polymer nanoparticles selective for glyphosate, MIP-Gly NPs, were devised, synthesized, and subsequently integrated…

17/05/2023

If we can make synthetic limbs for amputees and scaffolds to regenerate tissues, can we use chemistry to make synthetic affinity reagents? The answer is yes - head to page 18 in the latest edition of Laboratory News to learn more from our our Head of Chemistry https://cloud.3dissue.com/2153/2844/6246/laboratorynewsissue22023/index.html?r=25

15/05/2023

Are you facing challenges implementing continuous monitoring in your cell and gene therapy processes? nanoMIP based sensing could be the solution - chat with our CCO at ASGCT this week from May 16th – 20th in Los Angeles https://mipdiscovery.com/cell-and-gene-therapy-enablers/

With over 3000 cell and gene therapies in development, there is greater demand for reagents and processes to manufacture such treatments.  Cost remains a

10/05/2023

Our CCO Brian Burke will be attending the ASGCT meeting in Los Angeles from May 16th - 20th. Drop us a message to schedule a meeting if you would like to learn how nanoMIP affinity reagents can support cell and gene therapy processes.

09/05/2023

As fentanyl awareness day comes to a close, we encourage everyone to help raise awareness of the dangers of fentanyl abuse, carry naloxone, and know the signs of an overdose. Spread the word to save lives

09/05/2023

Fentanyl is involved in more deaths of Americans under 50 than any cause of death, including heart disease, cancer, homicide, su***de and other accidents. Learn more at www.fentanylawarenessday.org and spread the word to save a life.

A day of action to raise public awareness about an urgent problem: illegally made fentanyl. Join our effort on May 9, 2022.

08/05/2023

Tomorrow is - Fentanyl is odorless, tasteless, and extremely potent. It is used to make fake pills disguised as Oxycontin, Percocet and Xanax, and you can’t tell which pills contain a lethal amount. Learn the facts about fentanyl and share them with your friends at fentanylawarenessday.org.

28/04/2023

Fast and effective diagnostic testing is key to disease management but a challenge for antibody-based approaches. Animal/cell-free detection reagents present an opportunity for solutions at mass scale, explains Francesco Canfarotta in this new article, published by Laboratory News https://mipdiscovery.com/articles/synthetic-affinity-reagents-offer-new-possibilities-for-future-diagnostics/

27/04/2023

Our Head of Chemistry has been discussing the diagnostic capabilities of synthetic affinity reagents over on Laboratory News – Read the full article now https://www.labnews.co.uk/article/2093295/synthetic-affinity-reagents-new-possibilities-for-diagnostics

Fast and effective diagnostic testing is key to disease management but a challenge for antibody-based approaches. Animal/cell-free detection reagents pr...